Roivant Sciences is a company that develops and commercializes medicines. It provides drug candidates focusing on a range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, as well as rare and fatal pediatric conditions. The company also offers the Roivant platform and technologies built to address inefficiencies in the drug discovery, development, and commercialization process.